Countdown toNOPAIN Act:
Days
ASP+6% reimbursement for EXPAREL effective January 1, 2025, when billing with code J0666 across all outpatient surgical settings
At Pacira BioSciences, we have a capable and passionate team of people dedicated to serving our customers in a work environment that encourages collaboration. Our culture inspires and challenges individuals to be effective and efficient in all that they do, and our workforce has a passion for excellence.
We are committed to intentionally cultivating a culture of inclusion where all feel welcomed and valued for their background, perspectives, and experiences. We hold one another accountable to promote trust and transparency in support of our communities and collective purpose.
Marketing
Quality Assurance
Medical Innovation and Education
Rarely do you have an opportunity to do work that really matters. What drives us is our mission. What makes us successful are our people.
At Pacira, you are part of an inclusive culture that fosters collaboration, growth, and innovative thinking - a place where you can make an impact and help change the standard of care in non-opioid pain management. Be part of our movement, let’s pursue excellence together.
Inspire. Achieve. Celebrate. Repeat.
Our employees start each day with a new chance to transform healthcare. Whether you work in an office or in a lab, our purpose is the same – Improving patient outcomes.
we embrace patient safety & patient welfare as our top priorities at all times
we regularly celebrate the determination, dedication, & deep engagement of our people
we demonstrate unwavering entrepreneurial spirit, deep engagement & commitment to company goals & mission
we generously contribute thoughts & practical solutions to improve the efficiency & effectiveness of our business
we honor commitments & adhere to the highest ethical standards; treat all with dignity, respect, & fairness
teaming is the cornerstone of our business success; we demonstrate a strong commitment to teaming within & across organizational boundaries
Pacira BioSciences, Inc. is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability. If you have a disability and need assistance in applying, please contact HR@pacira.com. If you’d like to view a copy of the company’s affirmative action plan, please email HR@pacira.com.
Please see our Employee and Job Applicant Privacy Notice for more information on how Pacira handles their personal information.
Agency Disclaimer:
Pacira Biosciences, Inc. (Hereafter, Pacira) does not accept unsolicited resumes from recruiters
or employment agencies in response to the Pacira Careers page or a Pacira social media post.
Pacira will not consider or agree to payment of any referral compensation or recruiter fee
relating to unsolicited resumes. Pacira explicitly reserves the right to hire said candidate(s)
without any financial obligation to the recruiter or agency. Any unsolicited resumes, including
those submitted to hiring managers, are deemed to be the property of Pacira.
Effective January 1, 2025
NOPAIN Act provides expanded reimbursement for EXPAREL® (bupivacaine liposome injectable suspension)1
ASP+6% CMS reimbursement when billing EXPAREL with new code J0666 across outpatient settings2,3*
*For dates of service prior to January 1, 2025, Medicare reimbursement is available in ASCs when billing with C9290. For commercial or Medicare Advantage plans, please confirm with the individual payer.3
ASP+6% = reimbursement of 106% of the average sales price.
ASC, ambulatory surgical center; CMS, Centers for Medicare & Medicaid Services; NOPAIN, Non-Opioids Prevent Addiction in the Nation.
References: 1. Consolidated Appropriations Act 2023. Accessed October 30, 2024. https://www.congress.gov/117/bills/hr2617/BILLS-117hr2617enr.pdf; 2. CMS.gov. Medicare part B drug average sales price. Updated April 2, 2024. October 30, 2024. https://www.cms.gov/medicare/payment/fee-for-service-providers/part-b-drugs/average-drug-sales-price; 3. CMS.gov. Published October 10, 2024. Accessed October 30, 2024. https://www.cms.gov/files/document/2024-hcpcs-application-summary-quarter-3-2024-drugs-and-biologicals-posted-10-02-2024.pdf
